PMID: 16646285May 2, 2006Paper

Diagnostic and prognostic significance of serum soluble interleukin 2 receptor in children with malignancies

Wiadomości lekarskie : organ Polskiego Towarzystwa Lekarskiego
Ewa BieńDominik Ciesielski

Abstract

The significance of sIL-2R as a marker of pediatric malignancies activity has not been evaluated so far. The aim of the study was to determine the clinical role of sIL-2R in diagnostics and prognosis in children with neoplasms. The study included 61 children (F/M: 28/33, mean age 7.9 years) diagnosed with acute leukemias (ALL - 22, ANLL - 3), malignant lymphomas (HD - 12, NHL - 6), nephroblastoma and soft tissue sarcomas (Tu Wilms -10, SA- 8). Control group consisted of 30 healthy children (F/M: 15/15, mean age 8.8 years). Serum sIL-2R was measured by ELISA (DAKO, the Netherlands). Correlation of sIL-2R with age was stated thus the results have been presented as multiplication of the upper normal range (> 1 xN) determined for the patient's age at time of samples collection. Pre-treatment levels of sIL-2R in cancer patients were elevated as compared to controls, both regarding the whole oncological group and its subgroups: A (ALL + ANLL + NHL), B (HD) and C (Tu Wilms + SA) (p < 0.001). 92% of cancer patients presented with elevated levels of sIL-2R compared to 0% in healthy controls. sIL-2R levels were significantly higher in advanced stages of solid tumours and lymphomas and in children with HD and NHL with general symptoms and...Continue Reading

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.